Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Elusive cancer killer’s deep-sea hideout discovered after a nearly 20-year hunt

28.10.2003


In 1984, HARBOR BRANCH scientists exploring deep waters off the Bahamas in one of the institution’s Johnson-Sea-Link submersibles discovered a small piece of sponge that harbored a chemical with a remarkable ability to kill cancer cells in laboratory tests. Despite almost two decades of searching, though, the group was never able to find enough of the sponge to fully explore its potential. But now that process can finally begin because, thanks to some creative detective work, the team has found the animal’s secret hiding place and collected enough of it to support years of intense research.


The Johnson-Sea-Link I submersible, used to collect the promising sponge
Credit: HARBOR BRANCH


Amy Wright,director of Harbor Branch Biomedical Marine Research (right) and Shirley Pomponi, Harbor Branch vice-president and director of research, aboard the R/V Seward Johnson II sorting samples after a drug discovery submersible dive.
Credit: HARBOR BRANCH



"It’s just amazing," says Amy Wright, director of HARBOR BRANCH Biomedical Marine Research, of the sponge she has been on a career-long quest to find. "This is our next cure, I know it’s our next cure."

A chemical produced within the sponge, which has not yet been given an official name, has proven in one test of cancer-fighting potential to be about 400 times more potent than Taxol®, a widely used treatment for breast and other forms of cancer. As important, preliminary experiments have also shown the compound to be fairly non-toxic to normal cells.


But the limited amount of the sponge initially collected was not enough to carry the team through the long process of developing a potential medical treatment, which involves careful study of exactly how a chemical kills cancer cells and of its chemical structure. "Since 1984 it has been on our target list for every dive," says Wright, who first studied the compound as a postdoctoral fellow at HARBOR BRANCH during the ’80s.

On various expeditions over the years, scientists found only tiny pieces of the sponge, then last year two slightly larger pieces, but still they did not have enough to do the required research. So, in preparation for a cruise this year to the Bahamas that ran from Oct. 9 through the 24th, Wright and her team used clues from where each piece had been collected to put together a profile of the habitat where it must live.

The technique worked perfectly, and on the first submersible dive targeting an area that fit the profile, they found the sponge. "You know, you have these hypotheses, but when it is actually there, it just floors you that the hypothesis worked," says Wright, "We were really excited. I was just dancing around."

The sponge was found in water over 1,000 feet deep in an area the researchers often refer to as the "dead zone," because it is generally characterized by bare rock and very low biodiversity. The sponge, which can grow to about the size of a softball, had eluded researchers for so long because they generally avoid this area in favor of exploring more diverse habitats.

Wright predicts that the quantity of the sponge collected on the expedition using the submersible should be enough to carry the team through the full multi-year drug discovery process, possibly even to the first phase of human trials. "I never thought I would see that much of the sponge ever," says Wright, "Now we have enough to move forward."

If the chemical continues to show promise as the research process progresses, it would eventually be licensed to a pharmaceutical company, which would take the compound through clinical trials. A key step before that could happen would be for HARBOR BRANCH and its collaborators to develop a method to sustainably produce the chemical without having to collect it from wild sponges, which would be both economically and ecologically unfeasible. Possible methods would be raising the sponge through aquaculture, producing it synthetically, or, if the chemical turns out to be produced by a microorganism within the sponge, raising cultures of that microorganism. The full process of turning the chemical into a commercially available cancer treatment would likely take more than a decade.

The mystery sponge’s hideout was found on an expedition to the Bahamas that covered some 1,300 miles and took the team throughout the island chain almost as far south as the Turks and Caicos Islands. For more information about this expedition as well as background articles on the team’s research, please visit HARBOR BRANCH’s online expedition site at: http://www.at-sea.org

HARBOR BRANCH has already patented nearly a hundred potential pharmaceuticals from the tens of thousands of the organisms the Biomedical Marine Research group has collected since the ’80s at sites around the globe. Several of these are in various stages of development as potential commercial drugs. Discodermolide, a compound produced by a deepwater sponge found in the Bahamas, is currently in the first phase of human trials as a cancer treatment.

Mark Schrope | EurekAlert!
Further information:
http://www.hboi.edu/

More articles from Life Sciences:

nachricht Cancer diagnosis: no more needles?
25.05.2018 | Christian-Albrechts-Universität zu Kiel

nachricht Less is more? Gene switch for healthy aging found
25.05.2018 | Leibniz-Institut für Alternsforschung - Fritz-Lipmann-Institut e.V. (FLI)

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Powerful IT security for the car of the future – research alliance develops new approaches

The more electronics steer, accelerate and brake cars, the more important it is to protect them against cyber-attacks. That is why 15 partners from industry and academia will work together over the next three years on new approaches to IT security in self-driving cars. The joint project goes by the name Security For Connected, Autonomous Cars (SecForCARs) and has funding of €7.2 million from the German Federal Ministry of Education and Research. Infineon is leading the project.

Vehicles already offer diverse communication interfaces and more and more automated functions, such as distance and lane-keeping assist systems. At the same...

Im Focus: Molecular switch will facilitate the development of pioneering electro-optical devices

A research team led by physicists at the Technical University of Munich (TUM) has developed molecular nanoswitches that can be toggled between two structurally different states using an applied voltage. They can serve as the basis for a pioneering class of devices that could replace silicon-based components with organic molecules.

The development of new electronic technologies drives the incessant reduction of functional component sizes. In the context of an international collaborative...

Im Focus: LZH showcases laser material processing of tomorrow at the LASYS 2018

At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.

At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...

Im Focus: Self-illuminating pixels for a new display generation

There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?

At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

In focus: Climate adapted plants

25.05.2018 | Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

 
Latest News

In focus: Climate adapted plants

25.05.2018 | Event News

Flow probes from the 3D printer

25.05.2018 | Machine Engineering

Less is more? Gene switch for healthy aging found

25.05.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>